Human Hepatocytes, Cryopreserved Single Donor , Suspension
Human Hepatocytes, Cryopreserved Single Donor , Suspension
Cryopreserved Single Donor human hepatocytes are characterized for high viability and general Phase I and Phase II metabolism activity in short term suspension metabolism assays. Each ampule contains > 5 million cells.
You May Also Need...
Product Overview
Cryopreserved Single Donor human hepatocytes are characterized for high viability and general Phase I and Phase II metabolism activity in short term suspension metabolism assays. The Suspension Qualified hepatocytes are ideally suited from short-term (<4hrs) in vitro drug clearance assays. The Suspension Qualified hepatocytes are not suitable for applications that require hepatocytes cultured in adhered monolayers.
Request More InfoBenefits
- Precharacterized for general metabolism
- Certificate of Analysis (CoA) provided for every cell lot
Applications
- Suspension metabolism studies
Storage and Content
1 x Cryopreserved ampule Human Hepatocytes Suspension, Single Donor, containing >5 million viable cells
SDS, CoA, and Instructions
Safety Data Sheets (SDS)
Choose a language to view the SDS.
Certificate of Analysis (CoA)
Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.
Educational Material
Brochures, White Papers etc.
Videos
-
Webinar - Hepatocytes in the Drug Development Pipeline
Overview of how primary hepatocytes are used in drug development -
Primary hepatocytes in RAFT™ 3D Cell Culture System - A model for hepatocyte toxicity studies
A whitepaper reporting a 3D hepatocyte model constructed using the RAFT™ 3D Cell Culture System and characterization.
-
Designed for Purpose – Complex Liver Cell Cultures for Improving In Vitro Hepatotoxicity Testing
Recording of SOT 2018 Symposium presented by Drs. Jessica Hartman and Martin Phillips. -
3D Cultures of HepaRG™ Cells Model Physiologically Relevant Drug Metabolism, Drug-Induced Liver Injury, and Hepatic Signaling Pathways
Recording of SOT 2018 Symposium presented by Dr. Stephen Ferguson. -
Hepatocytes in the Drug Development Pipeline
Webinar describing how hepatocytes are used in drug development delivered by Dr. Salman Khetani, Professor at University of Illinois, Chicago.
